170 related articles for article (PubMed ID: 36604232)
1. Establishing and validating predictive nomograms for lateral pelvic lymph node metastasis in patients with rectal cancer based on radiologic factors and clinicopathologic characteristics.
Zhou S; Yang Y; Lou Z; Liang J; Wang X; Tang J; Liu Q;
Eur J Surg Oncol; 2023 Apr; 49(4):747-754. PubMed ID: 36604232
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
[TBL] [Abstract][Full Text] [Related]
3. Can neoadjuvant chemoradiotherapy before lateral pelvic lymph node dissection improve local control and prognosis in rectal cancer patients with clinically suspected lateral lymph node metastasis? A multicenter lateral node study in China.
Xie Z; Chen Q; Feng B; Jiang Y; Wang X; Xing W; Liu Q;
BMC Cancer; 2024 Jan; 24(1):115. PubMed ID: 38263067
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and prognostic significance of lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy for rectal patients with clinically suspected lateral lymph node metastasis.
Zhou S; Jiang Y; Pei W; Liang J; Zhou Z
BMC Surg; 2021 Dec; 21(1):441. PubMed ID: 34961494
[TBL] [Abstract][Full Text] [Related]
5. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
[TBL] [Abstract][Full Text] [Related]
6. Establishment and validation of a nomogram for predicting potential lateral pelvic lymph node metastasis in low rectal cancer.
Sumii A; Hida K; Sakai Y; Hoshino N; Nishizaki D; Akagi T; Fukuda M; Yamaguchi T; Takemasa I; Tokunaga T; Watanabe J; Watanabe M
Int J Clin Oncol; 2022 Jul; 27(7):1173-1179. PubMed ID: 35415787
[TBL] [Abstract][Full Text] [Related]
7. Evaluating predictive factors for determining the presence of lateral pelvic node metastasis in rectal cancer patients following neoadjuvant chemoradiotherapy.
Wang P; Zhou S; Zhou H; Liang J; Zhou Z
Colorectal Dis; 2019 Jul; 21(7):791-796. PubMed ID: 30801862
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemoradiotherapy followed by lateral pelvic lymph node dissection for rectal cancer patients: A retrospective study of its safety and indications.
Zhou S; Jiang Y; Pei W; Zhou H; Liang J; Zhou Z
J Surg Oncol; 2021 Sep; 124(3):354-360. PubMed ID: 33882149
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and safety of lateral pelvic lymph node dissection for elderly patients with middle-low rectal cancer: results of a large multicenter lateral node collaborative group study in China.
Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q
Tech Coloproctol; 2023 Aug; 27(8):655-664. PubMed ID: 36515808
[TBL] [Abstract][Full Text] [Related]
10. Predictors and histological effects of preoperative chemoradiotherapy for rectal cancer and control of lateral lymph node metastasis.
Miyakita H; Chan LF; Okada K; Kayano H; Mori M; Sadahiro S; Yamamoto S
BMC Gastroenterol; 2022 Jul; 22(1):334. PubMed ID: 35804299
[TBL] [Abstract][Full Text] [Related]
11. Establishment and validation of nomograms for predicting mesorectal lymph node staging and restaging.
Zhuang Z; Ma X; Zhang Y; Yang X; Wei M; Deng X; Wang Z
Int J Colorectal Dis; 2022 Sep; 37(9):2069-2083. PubMed ID: 36028723
[TBL] [Abstract][Full Text] [Related]
12. The influence of neoadjuvant chemoradiotherapy combined with lateral lymph nodes dissection or not on the local recurrence of low to intermediate-stage II/III rectal cancer.
Li C; Luan J; Ji X; Wang X; Li J; Li X; Zhou Y
J Surg Oncol; 2024 Feb; 129(2):273-283. PubMed ID: 37811551
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of Selective Lateral Node Dissection Based on Magnetic Resonance Imaging in Rectal Cancer After Preoperative Chemoradiotherapy.
Park BK; Lee SJ; Hur BY; Kim MJ; Chan Park S; Chang HJ; Kim DY; Oh JH
J Surg Res; 2018 Dec; 232():227-233. PubMed ID: 30463722
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: a propensity score matching study.
Zhou S; Jiang Y; Pei W; Liang J; Zhou Z
BMC Cancer; 2022 Feb; 22(1):136. PubMed ID: 35109810
[TBL] [Abstract][Full Text] [Related]
15. What is the role of lateral lymph node dissection in rectal cancer patients with clinically suspected lateral lymph node metastasis after preoperative chemoradiotherapy? A meta-analysis and systematic review.
Yang X; Yang S; Hu T; Gu C; Wei M; Deng X; Wang Z; Zhou Z
Cancer Med; 2020 Jul; 9(13):4477-4489. PubMed ID: 32352659
[TBL] [Abstract][Full Text] [Related]
16. [Can Lateral Pelvic Node Dissection Omitted in Rectal Cancer with Suspected Lateral Node Metastasis after Chemoradiotherapy ?].
Onishi T; Fujie Y; Adachi K; Nonaka R; Moon JH; Fujita S; Hashimoto K
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1473-1475. PubMed ID: 29394672
[TBL] [Abstract][Full Text] [Related]
17. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
[TBL] [Abstract][Full Text] [Related]
18. Preliminary experience with lateral pelvic lymph node dissection in locally advanced rectal cancer.
Sinukumar S; Engineer R; Saklani A
Indian J Gastroenterol; 2015 Jul; 34(4):320-4. PubMed ID: 26334237
[TBL] [Abstract][Full Text] [Related]
19. Does adding lateral pelvic lymph node dissection to neoadjuvant chemotherapy improve outcomes in low rectal cancer?
Law BZY; Yusuf Z; Ng YE; Aly EH
Int J Colorectal Dis; 2020 Aug; 35(8):1387-1395. PubMed ID: 32504333
[TBL] [Abstract][Full Text] [Related]
20. Mesorectal excision with lateral lymph node dissection for mid-low rectal cancer with lateral lymph node metastasis: efficacy and prognostic analysis.
Zhou S; Jiang Y; Liang J; Liu Q
World J Surg Oncol; 2022 Mar; 20(1):97. PubMed ID: 35351137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
